الرسائل الموجهة للمختصين الصحيين
الرسائل الموجهة للمختصين الصحيين
| المنتج | التاريخ | معلومات السلامة | المرفقات |
|---|---|---|---|
| Belimumab | 2019-03-25 | Benlysta (Belimumab) and Risk of serious Depression and/ or Suicidal ideation or Behavior or self-injury. |
|
| Xarelto ® (Rivaroxaban) | 2015-12-14 | Warnings and precautions for use to reduce the risk of bleeding.
|
|
| Valdoxan® - Agomelatine | 2014-03-19 | New contraindication for use and a reminder of importance of liver function monitoring. CLICK HERE |
|
| Roaccutane® - Isotretinoin | 2014-03-17 | Pregnancy Prevention Program and Safety Information about Roaccutane®. |
|
| VIREAD ® - Tenofovir | 2014-03-11 | Possible presence of silicone rubber in the above listed product and lots. |
|
| ZOFRAN® - Ondansetron | 2013-08-29 | Updated information on posology for intravenous use and dose dependant QT interval prolongation. |
|
| Solpadeine® - Paracetamol, Caffeine, Codeine Phosphate | 2013-05-07 | The use of codeine containing products for children after tonsillectomy and /or adenoidectomy surgery |
|
| MabThera® - Rituximab | 2013-04-01 | Risk of Toxic Epidermal Necrolysis And Stevens-Johnson-Syndrome |
|
| Yasmin® - drospirenone and ethinyl estradiol | 2011-10-23 | Risk of venous thromboembolism ( VTE )
|
|